Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 79

1.

High-Dose Erythropoietin and Hypothermia for Hypoxic-Ischemic Encephalopathy: A Phase II Trial.

Wu YW, Mathur AM, Chang T, McKinstry RC, Mulkey SB, Mayock DE, Van Meurs KP, Rogers EE, Gonzalez FF, Comstock BA, Juul SE, Msall ME, Bonifacio SL, Glass HC, Massaro AN, Dong L, Tan KW, Heagerty PJ, Ballard RA.

Pediatrics. 2016 Jun;137(6). pii: e20160191. doi: 10.1542/peds.2016-0191. Epub 2016 May 2.

PMID:
27244862
2.

Randomized Trial of Late Surfactant Treatment in Ventilated Preterm Infants Receiving Inhaled Nitric Oxide.

Ballard RA, Keller RL, Black DM, Ballard PL, Merrill JD, Eichenwald EC, Truog WE, Mammel MC, Steinhorn RH, Rogers EE, Ryan RM, Durand DJ, Asselin JM, Bendel CM, Bendel-Stenzel EM, Courtney SE, Dhanireddy R, Hudak ML, Koch FR, Mayock DE, McKay VJ, O'Shea TM, Porta NF, Wadhawan R, Palermo L; TOLSURF Study Group.

J Pediatr. 2016 Jan;168:23-9.e4. doi: 10.1016/j.jpeds.2015.09.031. Epub 2015 Oct 21.

PMID:
26500107
3.

Pharmacokinetics of Budesonide Administered with Surfactant in Premature Lambs: Implications for Neonatal Clinical Trials.

Roberts JK, Stockmann C, Dahl MJ, Albertine KH, Egan E, Lin Z, Reilly CA, Ballard PL, Ballard RA, Ward RM.

Curr Clin Pharmacol. 2016;11(1):53-61.

PMID:
26416605
4.

Comparisons and Limitations of Current Definitions of Bronchopulmonary Dysplasia for the Prematurity and Respiratory Outcomes Program.

Poindexter BB, Feng R, Schmidt B, Aschner JL, Ballard RA, Hamvas A, Reynolds AM, Shaw PA, Jobe AH; Prematurity and Respiratory Outcomes Program.

Ann Am Thorac Soc. 2015 Dec;12(12):1822-30. doi: 10.1513/AnnalsATS.201504-218OC.

PMID:
26397992
5.

Prematurity and respiratory outcomes program (PROP): study protocol of a prospective multicenter study of respiratory outcomes of preterm infants in the United States.

Pryhuber GS, Maitre NL, Ballard RA, Cifelli D, Davis SD, Ellenberg JH, Greenberg JM, Kemp J, Mariani TJ, Panitch H, Ren C, Shaw P, Taussig LM, Hamvas A; Prematurity and Respiratory Outcomes Program Investigators.

BMC Pediatr. 2015 Apr 10;15:37. doi: 10.1186/s12887-015-0346-3.

6.

Respiratory consequences of prematurity: evolution of a diagnosis and development of a comprehensive approach.

Maitre NL, Ballard RA, Ellenberg JH, Davis SD, Greenberg JM, Hamvas A, Pryhuber GS; Prematurity and Respiratory Outcomes Program.

J Perinatol. 2015 May;35(5):313-21. doi: 10.1038/jp.2015.19. Epub 2015 Mar 26. Review.

7.

Erythropoietin and hypothermia for hypoxic-ischemic encephalopathy.

Rogers EE, Bonifacio SL, Glass HC, Juul SE, Chang T, Mayock DE, Durand DJ, Song D, Barkovich AJ, Ballard RA, Wu YW.

Pediatr Neurol. 2014 Nov;51(5):657-62. doi: 10.1016/j.pediatrneurol.2014.08.010. Epub 2014 Aug 27.

8.

Inhaled nitric oxide increases urinary nitric oxide metabolites and cyclic guanosine monophosphate in premature infants: relationship to pulmonary outcome.

Ballard PL, Keller RL, Black DM, Durand DJ, Merrill JD, Eichenwald EC, Truog WE, Mammel MC, Steinhorn R, Ryan RM, Courtney SE, Horneman H, Ballard RA; Investigators of TOLSURF Pilot and TOLSURF.

Am J Perinatol. 2015 Feb;32(3):225-32. doi: 10.1055/s-0034-1382255. Epub 2014 Jun 26.

PMID:
24968129
9.

Late administration of surfactant replacement therapy increases surfactant protein-B content: a randomized pilot study.

Keller RL, Merrill JD, Black DM, Steinhorn RH, Eichenwald EC, Durand DJ, Ryan RM, Truog WE, Courtney SE, Ballard PL, Ballard RA.

Pediatr Res. 2012 Dec;72(6):613-9. doi: 10.1038/pr.2012.136. Epub 2012 Oct 4.

10.

Erythropoietin for neuroprotection in neonatal encephalopathy: safety and pharmacokinetics.

Wu YW, Bauer LA, Ballard RA, Ferriero DM, Glidden DV, Mayock DE, Chang T, Durand DJ, Song D, Bonifacio SL, Gonzalez FF, Glass HC, Juul SE.

Pediatrics. 2012 Oct;130(4):683-91. doi: 10.1542/peds.2012-0498. Epub 2012 Sep 24.

11.

Identifying abnormalities in symbiotic development between Trifolium spp. and Rhizobium leguminosarum bv. trifolii leading to sub-optimal and ineffective nodule phenotypes.

Melino VJ, Drew EA, Ballard RA, Reeve WG, Thomson G, White RG, O'Hara GW.

Ann Bot. 2012 Dec;110(8):1559-72. doi: 10.1093/aob/mcs206. Epub 2012 Sep 17.

12.

Inhaled nitric oxide in preterm infants: an individual-patient data meta-analysis of randomized trials.

Askie LM, Ballard RA, Cutter GR, Dani C, Elbourne D, Field D, Hascoet JM, Hibbs AM, Kinsella JP, Mercier JC, Rich W, Schreiber MD, Wongsiridej PS, Subhedar NV, Van Meurs KP, Voysey M, Barrington K, Ehrenkranz RA, Finer NN; Meta-analysis of Preterm Patients on Inhaled Nitric Oxide Collaboration.

Pediatrics. 2011 Oct;128(4):729-39. doi: 10.1542/peds.2010-2725. Epub 2011 Sep 19.

13.

Pilot trial of late booster doses of surfactant for ventilated premature infants.

Merrill JD, Ballard PL, Courtney SE, Durand DJ, Hamvas A, Hibbs AM, Lu KW, Ryan RM, Reynolds AM, Spence K, Steinhorn RH, Truog WE, Eichenwald EC, Ballard RA.

J Perinatol. 2011 Sep;31(9):599-606. doi: 10.1038/jp.2010.210. Epub 2011 Feb 10.

PMID:
21311500
14.

Re: 'The use of iNO in the newborn period: results from the European iNO registry'.

Golombek SG, Truog WE, Ballard RA, Ballard PL.

Acta Paediatr. 2010 Sep;99(9):1283. doi: 10.1111/j.1651-2227.2010.01847.x. No abstract available.

PMID:
20456263
15.

Inhaled nitric oxide in preterm infants: a systematic review and individual patient data meta-analysis.

Askie LM, Ballard RA, Cutter G, Dani C, Elbourne D, Field D, Hascoet JM, Hibbs AM, Kinsella JP, Mercier JC, Rich W, Schreiber MD, Srisuparp P, Subhedar NV, Van Meurs KP, Voysey M, Barrington K, Ehrenkranz RA, Finer N; Meta-Analysis of Preterm Patients on inhaled Nitric Oxide (MAPPiNO) Collaboration.

BMC Pediatr. 2010 Mar 23;10:15. doi: 10.1186/1471-2431-10-15. Review.

16.

Two-year neurodevelopmental outcomes of ventilated preterm infants treated with inhaled nitric oxide.

Walsh MC, Hibbs AM, Martin CR, Cnaan A, Keller RL, Vittinghoff E, Martin RJ, Truog WE, Ballard PL, Zadell A, Wadlinger SR, Coburn CE, Ballard RA; NO CLD Study Group.

J Pediatr. 2010 Apr;156(4):556-61.e1. doi: 10.1016/j.jpeds.2009.10.011. Epub 2010 Feb 6.

17.

Accounting for multiple births in neonatal and perinatal trials: systematic review and case study.

Hibbs AM, Black D, Palermo L, Cnaan A, Luan X, Truog WE, Walsh MC, Ballard RA.

J Pediatr. 2010 Feb;156(2):202-8. doi: 10.1016/j.jpeds.2009.08.049. Epub 2009 Dec 6. Review.

18.

Economic evaluation of inhaled nitric oxide in preterm infants undergoing mechanical ventilation.

Zupancic JA, Hibbs AM, Palermo L, Truog WE, Cnaan A, Black DM, Ballard PL, Wadlinger SR, Ballard RA; NO CLD Trial Group.

Pediatrics. 2009 Nov;124(5):1325-32. doi: 10.1542/peds.2008-3214. Epub 2009 Oct 19.

PMID:
19841125
19.

Inhaled nitric oxide in premature infants: effect on tracheal aspirate and plasma nitric oxide metabolites.

Posencheg MA, Gow AJ, Truog WE, Ballard RA, Cnaan A, Golombek SG, Ballard PL; NO CLD Investigators.

J Perinatol. 2010 Apr;30(4):275-80. doi: 10.1038/jp.2009.155. Epub 2009 Oct 8.

20.

Metaphysical and ethical perspectives on creating animal-human chimeras.

Eberl JT, Ballard RA.

J Med Philos. 2009 Oct;34(5):470-86. doi: 10.1093/jmp/jhp035. Epub 2009 Aug 19.

PMID:
19692673
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk